Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era류마티스 질환 및 염증성 장 질환에 대한 피하 인플릭시맙의 전망: COVID-19 시대 전, 중, 후Review Published on 2022-06-012022-09-12 Journal: Advances in therapy [Category] MERS, 진단, [키워드] administration anticipated approval benefit Biobetters bowel clinical advantage clinical benefit clinical trial coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 CT-P13 SC Drug administration Efficacy and safety gastroenterology Guidance hcp healthcare Healthcare professional Healthcare system Healthcare systems IBD implementation improvement Inflammatory bowel disease infliximab Innovative biologics intravenous IV infusion management Nosocomial infection offer pandemic Patient Patient care Patient satisfaction patients Physicians Potential preference provide real-world data Real-world evidence reduced reduction in Regulatory resource rheumatic disease Rheumatic diseases rheumatoid arthritis rheumatology risk selected significant changes in Subcutaneous Subcutaneous infliximab suggested Support supported switching Telemedicine therapy Treatment [DOI] 10.1007/s12325-021-01990-6 PMC 바로가기 [Article Type] Review
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort studyIBD 환자에서 SARS-CoV-2에 대한 항체 반응은 시간이 지남에 따라 감소합니다: 혈청 감시 코호트 연구Comment Published on 2022-06-012022-09-12 Journal: Gut [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract cohort study COVID-19 diminishe IBD IBD. individual SARS-CoV-2 [DOI] 10.1136/gutjnl-2021-325238 PMC 바로가기 [Article Type] Comment
Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination염증성 장 질환 치료가 SARS-CoV-2 백신 접종에 대한 체액 반응의 지속성에 미치는 영향Article Published on 2022-06-012022-09-12 Journal: Clinical gastroenterology and hepatology : the off [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] antibody Antibody Response booster vaccination clinical guideline Cohort dose Efficacy IBD immune-mediated disease Immunity Immunosuppressive medication Impact Inflammatory bowel disease outcomes Patient postvaccination Precaution recommendation reduce response SARS-CoV-2 SARS-CoV-2 vaccine Seroconversion the spike protein therapy time interval Transmission vaccination [DOI] 10.1016/j.cgh.2021.12.007 PMC 바로가기 [Article Type] Article
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel DiseaseSARS-CoV-2-mRNA 부스터 백신 접종은 면역 저하 환자의 무반응 및 조기 항체 약화를 역전시킵니다 - 고형암, 다발성 골수종 및 염증성 장 질환 환자의 면역 반응을 비교하는 4상 연구Clinical Trial Published on 2022-05-122022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] analyzed anamnestic response anamnestic vaccine-specific response antibody Antibody testing Autoimmune disease B-cell BNT162b2 booster booster vaccination Cancer patients CD19 cellular cellular response Control control group controls correlated COVID-19 cytokine response declined Effectiveness EudraCT group help highest humoral humoral and cellular vaccine-specific responses IBD identify IFN-γ response IgG IgG level IL-2 immune responses immunodeficiency IMPROVE individual Inflammatory bowel disease inhibitor inhibitors intervals knowledge mRNA mRNA vaccination mRNA-1273 Multiple Multiple myeloma Myeloma neutralizing antibody non-infected Open-label Patient patients patients treated patients under immunosuppression/immunomodulation Patients with cancer persistence phase response SARS-CoV-2 SARS-CoV-2 mRNA vaccination SARS-CoV-2 vaccination second dose Solid solid tumor SOT TNF-α Trial undetectable vaccination Vaccine waning of immune responses. [DOI] 10.3389/fimmu.2022.889138 PMC 바로가기 [Article Type] Clinical Trial
Ulcerative colitis as a possible sequela of COVID-19 Infection: The endless storyArticle Published on 2022-05-012023-07-09 Journal: Arab Journal of Gastroenterology [Category] COVID19(2023년), [키워드] COVID-19 IBD Post-COVID syndromes ulcerative colitis [DOI] 10.1016/j.ajg.2022.01.006 PMC 바로가기
Impact of COVID-19 pandemic on pediatric endoscopy: A multicenter study on behalf of the SIGENP Endoscopy Working GroupResearch article Published on 2022-05-012022-10-05 Journal: Digestive and liver disease : official journal of [Category] COVID19(2023년), SARS, 진단, [키워드] collected COVID-19 COVID-19 pandemic diagnose Diagnostic endoscopy digestive drastic reduction endoscopy Follow-up Gastrointestinal group healing IBD Impact indication Italian Italy median multicenter pediatric Pediatric Endoscopy performed provide real-world data reduced reduction reported response Result selected significant decrease significantly the median Volume working [DOI] 10.1016/j.dld.2022.02.010 [Article Type] Research article
Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview염증성 장 질환: 임상 진단 및 외과적 치료-개요Review Published on 2022-04-212022-09-11 Journal: Medicina [Category] 진단, 치료제, [키워드] adoption anatomical best bowel Care Characteristics clinical Clinical diagnosis clinical diagnosis guideline clinically Colitis colitis-associated colorectal cancer colonic Colorectal cancer Conservative conservative treatment continuity Continuity of care COVID-19 COVID-19 pandemic criteria Crohn’s colitis Diagnosis diagnostic diagnostic challenges diagnostics disease disease phenotype dysplasia Early detection explicit fistula Follow-up gastrointestinal hemorrhage global pandemic healthcare histopathological IBD IBD care during COVID-19 pandemic idiopathic ileal indeterminate colitis indicated Inflammatory Inflammatory bowel disease inflammatory disorder Intervention intractable less limitation luminal management molecular molecular diagnostics molecular diagnostics advances Montreal Obstructive organization Patient peritonitis phenotype professionals promote recommendation Research resulting risk scar scar tissue severity Signs and symptoms similarity Stratification subtype surgical surgical intervention surgical interventions surgical treatment surgical treatment guidelines Surveillance Symptom the disease tissue Treatment ulcerative ulcerative colitis uneven representation of socioeconomic strata. [DOI] 10.3390/medicina58050567 PMC 바로가기 [Article Type] Review
Impact of COVID-19 Pandemic on the Quality of Life of IBD PatientsObservational Study Published on 2022-04-192022-10-05 Journal: Medicina [Category] 임상, [키워드] Affect All the patient average bowel conducted COVID-19 COVID-19 pandemic diagnosed Diagnosis evaluated group Healthcare systems IBD Impact Inflammatory Inflammatory bowel disease life material medical service objective Patient Quality Quality of life recorded recruited Result significant difference significantly lower [DOI] 10.3390/medicina58050562 PMC 바로가기 [Article Type] Observational Study
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease염증성 장 질환에서 클래스 I 및 클래스 II 특정 T 세포 수용체 간의 SARS-CoV-2 백신 반응 역학의 차이Article Published on 2022-04-082022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 유전자 메커니즘, 진단, [키워드] Ad26 Ad26.COV2.S Adaptive immune response adaptive immune responses age analyzed antibody antibody levels Antigen antigens BNT162b2 booster bowel characterized clone clones Cohort conditions Critical deficiencies deficiency difference Dynamics expansion Factor HCWs Health care Health care worker health care workers IBD immune factors immune response immune responses Immune-mediated immunodeficiency immunomodulatory induce Infection Inflammatory Inflammatory bowel disease inflammatory disease Inflammatory diseases intestinal mechanism molecular mRNA mRNA vaccine mRNA-1273 vaccine Patient patients protocols response responses robust SARS-CoV-2 SARS-CoV-2 (COVID-19) SARS-CoV-2 vaccination sequenced Sequencing significant difference significant differences Spectrum stratified subset T-cell T-cell receptor T-cell repertoire T-cell Response T-cell responses T-cells TCR the patient Treatment understanding vaccination vaccination response vaccination schedule Vaccine [DOI] 10.3389/fimmu.2022.880190 PMC 바로가기 [Article Type] Article
The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational studyObservational Study Published on 2022-04-012022-10-05 Journal: Alimentary pharmacology & therapeutics [Category] 임상, [키워드] 30-Day mortality acute ulcerative colitis Admission affected average bowel Care Cohort Community COVID-19 Crohn’s disease decrease Delay disease England estimates exacerbated hospital IBD Inflammatory bowel disease median outcome pandemic Prevalence Quality of life readmission reduction secondary care significant difference surgery Treatment ulcerative colitis Volume [DOI] 10.1111/apt.16800 PMC 바로가기 [Article Type] Observational Study